Hypertension (high blood pressure) Board decisions

The Board has decided that the evidence is insufficient to dismiss the Veteran's inquiry about the PACT Act, and thus remanded for further development regarding potential toxic exposures.

The Veteran's hypertension, left ventricular hypertrophy, cerebrovascular accident (stroke), bilateral upper and lower extremity peripheral neuropathy are all granted as service connected.,Dextrocardia is denied due to not being a disability for VA compensation purposes.

The Board has vacated the May 16, 2022 decision and remanded the service connection issues for diabetes mellitus, type II, hypertension, heart disability, and respiratory disability. The claims are now being addressed based on new evidence.

The Board has granted service connection for hypertension due to exposure to herbicide agents under the PACT Act, effective August 10, 2022. However, an earlier effective date is denied as the Veteran did not file a claim within one year of the enactment of the PACT Act.

The Veteran was granted service connection for bilateral hearing loss and tinnitus, but denied service connection for high blood pressure.,The Board found that the Veteran's military service likely exposed him to noise hazards, which contributed to his current conditions.

The Board has found that the Veteran's service connection claims for hepatocellular carcinoma, coronary artery disease, diabetes mellitus type II, hypertension, diabetic nephropathy, obstructive sleep apnea, iron deficiency anemia, and erectile dysfunction are remanded due to a failure to verify the Veteran's exposure to herbicide agents while stationed in Korea.

The Board has granted service connection for hypertension on a direct basis. The heart disorder claim is remanded due to duty-to-assist error.

The Veteran's acquired psychiatric disabilities, including unspecified depressive disorder and unspecified anxiety disorder, are granted as secondary to her service-connected musculoskeletal and neural disabilities.,Service connection for PTSD is denied because the Veteran does not meet the DSM-5 criteria for a diagnosis of PTSD.

The Board has determined that additional examinations are needed to address the Veteran's claims for service connection due to deficiencies in previous examination reports and failure to evaluate certain disorders.

The Veteran's diabetes and hypertension are granted as presumptively related to exposure to herbicide agents during service in Korea. However, the claim for glaucoma is denied.,Service connection for hypertension is granted based on the presumption of herbicide agent exposure, effective from August 10, 2022 (PACT Act).,The Veteran's glaucoma is not found to be related to service or herbicide exposure.

Service connection is granted for bilateral dry eye syndrome, tinnitus, and migraine headaches. Service connection is denied for acquired psychiatric disorder, hypertension, erectile dysfunction, right knee disability, left knee disability loss, left hip disability, right foot disability loss, lumbar spine disability, and skin rash.

The Veteran's hypertension is not rated as compensable, but his left knee disability has been granted service connection.,The claim for bilateral hearing loss is remanded due to a duty-to-assist error.

The Veteran's hypertension was not shown to be related to service and is denied.,Bilateral hearing loss did not meet the VA criteria for a disability, thus denial.,There is no evidence of a current left ankle disability, leading to denial.,Right ankle disability also lacks a current diagnosis, resulting in denial.

The Veteran's hypertension is granted as presumptively related to herbicide agent exposure during service, due to the PACT Act of 2022. The Board found that the Veteran was exposed to herbicide agents in the territorial seas of Vietnam while serving on USS Enterprise and Oriskany.

The Board has remanded the Veteran's claims for hypertension and urticaria as secondary to service-connected disabilities due to inadequate medical opinions.

The Veteran withdrew his appeal, specifically the issues of hypertension as secondary to PTSD and right knee strain, osteoarthritis (limitation of flexion). As a result, the Board dismissed the appeal.

The Veteran withdrew his appeal for service connection for hypertension, which was previously denied due to lack of new and material evidence.

The Board denied the Veteran's claims for service connection for hypertension, headaches, and open angle glaucoma. The evidence did not support a finding that these conditions were incurred or aggravated by service.,Specifically, the Board found no chronicity of HTN within one year after separation from active duty, and there was no credible evidence linking it to service exposure.

The Board denied service connection for various conditions, including psychiatric disorders, bilateral leg swelling, diabetes mellitus, right knee and ankle pain, left hip pain, chronic back pain, hypertension, headaches, and prostate cancer. The evidence did not support a finding that these conditions were related to service or the presumption of herbicide exposure.

The Veteran's service-connected hypertension has been rated as noncompensable (0 percent) since August 10, 2022. The Board found that the Veteran's hypertension does not meet the criteria for a compensable rating under Diagnostic Code 7101.